Concurrent CIS-platinum and radiation with or without surgery for advanced head and neck cancer
Arvin S. Glicksman(Roger Williams Medical Center), Harry Wanebo(Roger Williams Medical Center), Noreen Coachman(Roger Williams Medical Center), Gus J. Slotman(Apple (Israel)), James Koness(Roger Williams Medical Center), Jeffrey W. Clark(Massachusetts General Hospital), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Charles Doolittle(Roger Williams Medical Center), Eolo Derosa(United States Department of Veterans Affairs)
International Journal of Radiation Oncology*Biology*Physics
December 1, 1994
Cited by 66
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k